Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.67 |
| ▸ | MAFG | O15525 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 5/20 | 0.58 |
| ▸ | HTT | P42858 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | NT5E | P21589 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | GLS | O94925 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27353701 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL30696799 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL30696779 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL27353872 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL30696802 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL30696712 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL30696801 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL30696825 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL30696749 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 | |
| SCHEMBL27353390 | 1.00 | SMN1; SMN2 (0.67) | SMN1; SMN2POLBMAFGHPGDNFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543439-A2 | NRF2 PROTEIN DEGRADERS | Ganymede Oncology, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119730847-A | NRF2 protein degradation agent | 盖尼米德肿瘤学股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024006742-A2 | NRF2 PROTEIN DEGRADERS | DRACEN PHARMACEUTICALS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |